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Key points
 In the Western world, obesogenic diets containing high fat and high sugar (HFHS) are
commonly consumed during pregnancy, although their effects on the metabolism of the
mother, in relation to feto-placental glucose utilization and growth, are unknown.
 In the present study, the consumption of an obesogenic HFHS diet compromised maternal
glucose tolerance and insulin sensitivity in late pregnancy in associationwith dysregulated lipid
and glucose handling by the dam.
 These maternal metabolic changes induced by HFHS feeding were related to altered
feto-placental glucose metabolism and growth.
 A HFHS diet during pregnancy therefore causes maternal metabolic dysfunction with
consequences for maternal nutrient allocation for fetal growth.
 These findings have implications for the health of women and their infants, who consume
obesogenic diets during pregnancy.
Abstract In the Western world, obesogenic diets containing high fat and high sugar (HFHS) are
commonly consumed during pregnancy. However, the impacts of a HFHS diet during pregnancy
on maternal insulin sensitivity and signalling in relation to feto-placental growth and glucose
utilization are unknown. The present study examined the effects of a HFHS diet during mouse
pregnancy on maternal glucose tolerance and insulin resistance, as well as, on feto-placental
glucose metabolism. Female mice were fed a control or HFHS diet from day (D) 1 of pregnancy
(term = D20.5). At D16 or D19, dams were assessed for body composition, metabolite and
hormone concentrations, tissue abundance of growth andmetabolic signalling pathways, glucose
tolerance and utilization and insulin sensitivity. HFHS feeding perturbed maternal insulin
sensitivity in late pregnancy; hepatic insulin sensitivity was higher, whereas sensitivity of the
skeletal muscle and white adipose tissue was lower in HFHS than control dams. These changes
were accompanied by increased adiposity and reduced glucose production and glucose tolerance
of HFHS dams. The HFHS diet also disturbed the hormone and metabolite milieu and altered
expression of growth and metabolic signalling pathways in maternal tissues. Furthermore, HFHS
feeding was associated with impaired feto-placental glucose metabolism and growth. A HFHS
diet during pregnancy therefore causes maternal metabolic dysfunction with consequences for
maternal nutrient allocation for fetal growth. These findings have implications for the health of
women and their infants, who consume HFHS diets during pregnancy.
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Introduction
In the developed Western world, women of child-bearing
age obtain a high proportion of their energy intake
from fat and/or sugar (Balanza et al. 2007; Temme
et al. 2010; Austin et al. 2011). These dietary habits are
contributing to the increasing number ofwomenwho gain
excessweightduringpregnancy and/ordevelopgestational
diabetes (GDM); a condition affecting 5–10% of pre-
gnant women (Schieve et al. 1998; Agha-Jaffar et al. 2016;
Koning et al. 2016). Increased maternal fat deposition
and/or obesity during pregnancy are also associated with
health complications for the mother and infant after birth
(Thorsdottir et al. 2002; Berggren et al. 2016). Mothers
gaining excess weight during pregnancy have a greater
probablility of retaining the weight post-delivery and are
at increased risk of obesity, type-2 diabetes and cardio-
vascular disease later in life (Frias &Grove, 2012; Berggren
et al. 2016). Their infants are also often of abnormal
birth weight and more prone to obesity, hypertension
and type-2 diabetes as adults (Thorsdottir et al. 2002;
Oken et al. 2007; Frias & Grove, 2012). Experimental
animal studies have supported the human observational
studies and shown that feeding diets high in fat and/or
sugar during pregnancy programs metabolic dysfunction
in the adult offspring (Khan et al. 2005; Samuelsson et al.
2008; Elahi et al. 2009; Ashino et al. 2012; Franco et al.
2012; Alfaradhi et al. 2014; Fernandez-Twinn et al. 2014).
However, the mechanisms operating during pregnancy
that mediate the programming effects of these diets on the
mother and her offspring remain largely unknown.
To sustain pregnancy and fetal growth, nutrients must
be appropriately partitioned between the gravid uterus
and mother. To achieve this, the mother’s metabolism
is shifted to a more insulin resistant state such that
her own glucose utilization is limited, in favour of fetal
supply (Butte, 2000; Catalano et al. 2002; Musial et al.
2016). Whole body insulin resistance during pregnancy
results from changes in the action of insulin in the liver,
skeletal muscle and adipose tissue. These adaptations are
assumed to be signalled, in part by changes in placental
hormone production. In non-pregnant animals, insulin
resistance and altered insulin signalling in these tissues
are observed in response to feeding Western-style diets
high in fat and sugar (HFHS) (Um et al. 2004; Wang
et al. 2015; Zhang et al. 2015). However, the effects
of feeding HFHS diets during pregnancy on insulin
sensitivity and tissue insulin signalling pathways in the
pregnant mother remain unknown. Furthermore, it is not
clear whether feto-placental glucose utilization is altered
in these circumstances. Therefore, the present study aimed
to examine the effects of a HFHS diet during mouse
pregnancy on maternal glucose tolerance and insulin
resistance and on feto-placental glucose metabolism. It
also determined the effect of HFHS feeding on placental
expression of prolactin/placental lactogen (Prl/Pl) related
genes, which change with gestational age and have
proposed metabolic effects in the mother (Simmons et al.
2008).
Methods
Animals
All experiments were carried out under the UK Home
Office Animals (Scientific Procedures) Act 1986, following
ethical review by the University of Cambridge. C57Bl/6
females were housed under a 12:12 h dark/light photocycle
with free access to water and a standard rodent diet (RM3;
Special Dietary Services, Witham, UK). At 8–12 weeks
of age, 92 females were mated with C57Bl/6 males and
the day of copulatory plug detection was defined as day
(D)1 of pregnancy. From D1, females were maintained
on either the standard diet (n = 50) or were fed a
HFHS diet (n = 42). The nutritional composition of
both diets has been reported previously (Sferruzzi-Perri
et al. 2013). All procedures were performed on either
D16 or D19 of pregnancy and mice were allocated for
tissue and blood collection, a glucose tolerance test or a
hyperinsulinaemic-euglycaemic clamp.
Tissue and blood collection
Between 08.00 and 10.00 h, unfasted pregnant dams
(n= 10 per diet, per age) were weighed and anaesthetized
(10μl g−1 fentanyl-fluanisone:midazolam in sterile water,
1:1:2; I.P.; Janssen Animal Health, Beerse, Belgium). A
cardiac blood sample was taken before death by cervical
dislocation. Liver and retroperitoneal white adipose tissue
(WAT) were dissected, weighed and snap frozen in
liquid nitrogen for western blotting. Maternal skeletal
muscle (biceps femoris) was also dissected and snap
frozen. Blood glucose concentrationsweremeasuredusing
a hand-held glucometer (One Touch Ultra; LifeScan,
Johnson& JohnsonMedical Ltd, Livingston, UK). At D19,
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Table 1. The effect of HFHS feeding on maternal hormone and metabolite concentrations and biochemical composition of liver,
skeletal muscle and white adipose tissue at day 16 of pregnancy
Control HFHS
Tissue weights
Maternal whole body (g) 31.4 ± 1.1 29.0 ± 0.5∗
Maternal hysterectomized (HW, g) 24.1 ± 0.7 22.6 ± 0.4
Maternal liver (g) 1.90 ± 0.06 1.68 ± 0.05∗
Maternal liver (% HW) 7.9 ± 0.1 7.5 ± 0.2
Maternal WAT (g) 0.08 ± 0.01 0.11 ± 0.01∗
Maternal WAT (% HW) 0.31 ± 0.03 0.46 ± 0.04∗
Average fetus for litter (mg) 427 ± 12 394 ± 5∗
Average placenta for litter (mg) 104 ± 2 94 ± 2∗
Total fetal mass/total placental mass per litter 4.1 ± 0.1 4.2 ± 0.1
Viable pups per litter 7.5 ± 0.5 7.0 ± 0.4
Hormones and metabolites
Blood glucose fed state (mM) 10.3 ± 0.3 11.8 ± 0.6∗
Fasted 6 h (mM) 6.8 ± 0.2 7.6 ± 0.4∗
Plasma NEFA (μM) 256 ± 42 256 ± 29
Plasma TG (mM) 1.2 ± 0.2 0.8 ± 0.1∗
Plasma cholesterol (mM) 1.4 ± 0.1 2.2 ± 0.1∗
Plasma insulin (μg l–1) 1.3 ± 0.3 2.8 ± 0.5∗
Plasma leptin (pg ml–1) 4058 ± 656 13835 ± 2095∗
Plasma IGF1 (pg ml–1) 299 ± 23 193 ± 29∗
Plasma corticosterone (ng ml–1) 852 ± 160 849 ± 100
Tissue composition
Liver
Protein content (mg g–1) 177 ± 7.0 187 ± 13
Glycogen (mg g–1) 49 ± 1.1 54 ± 6.0
Total glycogen (mg) 86 ± 3.3 90 ± 11.9
Fat content (%) 5.1 ± 0.3 6.4 ± 0.8
Total fat content (mg) 91 ± 6.1 105 ± 12.8
Skeletal muscle
Protein content (mg g–1) 71 ± 4.3 73 ± 8.0
Fat content (%)† 15 15
WAT
Protein content (mg g–1) 27 ± 3.5 14 ± 1.0∗
Data are from dam in fed state, unless otherwise indicated. Data are expressed as the mean ± SEM with 11–15 dams per diet, 5–16
per diet for plasma analysis and 5 or 6 dams per diet for biochemical composition. The effect of the diet was analysed by an unpaired
t test. ∗Significant difference from control diet (P < 0.05). †Skeletal muscle fat content was measured on samples pooled from 4 or 5
animals from each experimental group. HW, hysterectomized weight.
the maternal liver was also fixed in 4% paraformaldehyde,
dehydrated and embedded into paraffin wax before
sectioning at 8 μm and staining with haematoxylin and
eosin. Tissues and blood taken from dams in the pre-
viously published cohort (Sferruzzi-Perri et al. 2013),
contributed to the samples used for biometrical and
biochemical analyses on the mother and placental gene
expression.
Glucose tolerance test (GTT)
Conscious dams underwent a GTT on D16 or D19
(n = 6–9 per diet, per age) after fasting from 08.00 h
for 6 h. Blood samples (5 μl) were taken from the
tail vein immediately before I.P. glucose administration
(10% w/v, 1 g kg−1 body weight) and, subsequently,
at 15, 30, 45, 60, 90 and 120 min to measure glucose
concentrations as above. Mice were then killed by cervical
dislocation.
Hyperinsulinaemic-euglycaemic clamp (HEC)
The HEC was performed as described previously
(Musial et al. 2016) on D19 mice. Mice fasted for
2.5 h (n = 6 per diet) were anaesthetized with
a mixture of ventranquil:dormicum:fentanyl (1:2:10
in 3 units of water, 10 μl g−1 body weight,
I.P., Janssen-Cilag, Tilburg, The Netherlands) and
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Table 2. The effect of HFHS feeding on maternal hormone and metabolite concentrations and biochemical composition of liver,
skeletal muscle and white adipose tissue at day 19 of pregnancy
Control HFHS
Tissue weights
Maternal whole body (g) 35.7 ± 1.0 35.1 ± 0.8
Maternal hysterectomized (HW, g) 24.0 ± 0.6 23.1 ± 0.4
Maternal liver (g) 1.86 ± 0.07 1.68 ± 0.06
Maternal liver (% HW) 8.0 ± 0.3 7.4 ± 0.2
Maternal WAT (g) 0.06 ± 0.01 0.08 ± 0.01
Maternal WAT (% HW) 0.27 ± 0.03 0.35 ± 0.03
Average fetus for litter (mg) 1200 ± 14 1184 ± 18
Average placenta for litter (mg) 89 ± 2 82 ± 2∗
Total fetal mass/total placental mass per litter 13.6 ± 0.3 14.4 ± 0.4
Viable pups per litter 7.3 ± 0.4 7.6 ± 0.4
Hormones and metabolites
Blood glucose fed state (mM) 9.4 ± 0.6 10.2 ± 0.6
Fasted 6 h (mM) 5.2 ± 0.3 5.2 ± 0.3
Plasma NEFA (μM) 381 ± 41 225 ± 38∗
Plasma TG (mM) 1.0 ± 0.1 0.7 ± 0.1
Plasma cholesterol (mM) 1.0 ± 0.1 1.2 ± 0.1
Plasma insulin (μg l–1) 0.6 ± 0.1 1.2 ± 0.5
Plasma leptin (pg ml–1) 3927 ± 709 5648 ± 1078
Plasma IGF1 (pg ml–1) 253 ± 20 205 ± 29
Plasma corticosterone (ng ml–1) 797 ± 115 750 ± 82
Tissue composition
Liver
Protein content (mg g–1) 186 ± 5.8 177 ± 4.6
Glycogen (mg g–1) 57 ± 6.2 55 ± 3.3
Total glycogen (mg) 103 ± 10.6 87 ± 8.8
Fat content (%) 4.7 ± 0.2 8.6 ± 0.8∗
Total fat content (mg) 86 ± 5.9 138 ± 17.7∗
Skeletal muscle
Protein content (mg g–1) 74 ± 5.0 57 ± 6.1∗
Fat content (%)† 20 31
WAT
Protein content (mg g–1) 28 ± 3.0 18 ± 3.3∗
Data are from dam in fed state, unless otherwise indicated. Data are expressed as the mean ± SEM with 12–22 dams for tissue
weights, 5–16 per diet for plasma analysis and 5 or 6 dams per diet for biochemical composition. The effect of the diet was analysed
by unpaired t test. ∗Significant difference from control diet (P < 0.05). †Skeletal muscle fat content was measured on samples pooled
from 4 or 5 animals from each experimental group. HW, hysterectomized weight.
maintained at 37°C using a servo-controlled thermo-
pad (Harvard Instruments, Cambournse, UK). After
catheterizing a tail vein, D-3H-glucose was infused
continuously (0.006 MBq min−1 in PBS, 50 μl h−1, I.V.,
370–740 GBq mmol−1; PerkinElmer, Wokingham, UK).
After steady-state was achieved at 60 min (basal state,
3.5 h fasted), two blood samples were taken 10 min
apart. Insulin was then injected as a bolus (3.3 mU,
I.V.; human insulin; Actrapid; Novo Nordisk, Bagsværd,
Denmark) followed by infusion (0.09mUmin−1) together
with the D-3H-glucose. Blood glucose concentrations were
monitored throughout the protocol and a variable rate
glucose infusion (12.5% w/v PBS, Sigma, I.V.) was begun
10min later tomaintainbloodglucose atmeanbasal levels.
At 50 min after insulin administration, 2-deoxy-glucose
(14C-2DG, specific activity: 9.25–13.0 GBq mmol−1;
PerkinElmer) was injected I.V. By 70 min of insulin
administration, blood glucose levels were clamped at basal
concentrations and a further three blood samples were
collected at 10 min intervals. Mice were then killed by
cervical dislocation and samples of biceps femoris and
white adipose tissue were collected together with the
fetus and placenta adjacent to the cervix in each horn
(n = 2 fetuses and placentas per litter) for analysis of
tissue 14C-2DG content. Rates of glucose utilization and
production andwhole body and hepatic insulin sensitivity
were calculated as described previously (Voshol et al.
2001).
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Hormone and metabolite concentrations
Plasma D-3H-glucose was measured by scintillation
counting (Hidex 300SL; LabLogic Ltd, Sheffield, UK),
plasma leptin, insulin, triglycerides (TG), cholesterol,
non-esterified free fatty acids (NEFA) and insulin-like
growth factor-1 (IGF1) concentrations determined by
immuno and enzymatic assays (Musial et al. 2016), and
plasma corticosterone measured by radioimmunoassay
A
C
B
D
E F
*
G
H
Control HFHS
Control HFHS
G6Pase
PEPCK
Ponceau
Ponceau
R
el
at
iv
e 
pr
ot
ei
n 
ex
pr
es
si
on
R
el
at
iv
e 
pr
ot
ei
n 
ex
pr
es
si
on
G6Pase PEPCK
Control HFHS Control HFHS
200
150
100
50
0
200
150
100
50
0
Figure 1. The effect of HFHS feeding on maternal hepatic fat
accumulation and glucose handling on day 19 of pregnancy
Representative photomicrographs of haematoxylin and eosin-stained
liver sections from dams at D19 that were fed a control (A and B) or
HFHS diet (C and D). Photos taken under 10× (A and C) and 40×
objective lens (B and D). Hepatic abundance of G6Pase (E and G) and
PEPCK (F and H) in control (n = 5) and HFHS dams (n = 6) at D19.
∗P < 0.05. [Colour figure can be viewed at wileyonlinelibrary.com]
(MP Biomedicals, Carlsbad, CA, USA) (Sferruzzi-Perri
et al.2011). Plasma insulin concentrations during theHEC
were measured by ELISA (Crystal Chem, Inc., Downer’s
Grove, IL, USA), which detected both mouse and human
(Musial et al. 2016).
Tissue biochemical composition
Hepatic glycogen content was measured enzymatically
using amyloglucosidase as reported previously (Roehrig
& Allred, 1974). The fat content of the liver and
pooled samples of skeletal muscle were measured using
the modified Folch method (Folch et al. 1957). To
determine tissue phosphorylated 2DG (p2DG) content,
maternal tissues and whole fetuses were homogenized in
0.5% perochloric acid and the homogenates neutralized
to separate p2DG from 2DG by precipitation before
scintillation counting, as described previously (Musial
et al. 2016).
Tissue protein expression
Proteins were extracted (50–100 mg, n = 5–6 per diet
per age) from the maternal liver, skeletal muscle andWAT
for assessment of insulin signalling and lipid metabolism
pathways using western blotting as described previously
(Musial et al. 2016). In addition, phosphoenolpyruvate
carboxykinase (PEPCK) and glucose 6-phosphatase
(G6Pase) were detected using antibodies from Santa Cruz
Biotechnology (Santa Cruz, CA, USA) (sc-32789 and
sc-27198, respectively). Protein bands were quantified
using ImageJ (National Institutes ofHealth,Bethesda,MD,
USA). To control for variations in loading, expression of
the proteins of interest was normalized to a corresponding
bandof similarmolecularweight on theponceauS-stained
membrane.
Placental gene expression
RNA was extracted from placentas with the second light-
est weight for the litter using the RNeasy Plus Mini
Kit (Qiagen, Manchester, UK). RNA was then reverse
transcribed using Multiscribe Reverse Transcriptase with
random primers (Applied Biosystems, Foster City, CA,
USA) and analysed in duplicate using Taqman assays
for Prl/Pl-related genes, Prl5a1, Prl2b1, Prl7b1, Prl7a2,
Prl3d1 and Prl3b1 (Mm00517851 m1, Mm01163874 m1,
Mm01164616 m1, Mm00478316 m1, Mm04213281 m1
andMm00435852 m1, respectively) and the housekeepers
Hprt and Gadph (Mm00446968 and Mm99999915 g1,
respectively). The genes of interest were normalized to
the geometric mean expression levels of the housekeepers,
which remained constant across diets and age. Data were
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analysed using the 2–CT method (Sferruzzi-Perri et al.
2013).
Statistical analysis
Data are reported as the mean ± SEM. All statistical
analyses and calculations were performed using Prism
(GraphPad Software Inc., SanDiego, CA, USA). The effect
of diet at different ages was assessed using an unpaired
t test. Changeswithin the samedietary groupwere assessed
by a paired t test. In the GTT protocol, the changes in
glucose concentration were analysed by two-way ANOVA
with time as a repeated measure and the area under the
curve (AUC) calculated using the trapezoid rule. P < 0.05
was considered statistically sigificant.
Results
Biometry
OnD16ofpregnancy,wholebodybutnothysterectomized
weight was lower for HFHS compared to control dams
(Table 1). HFHS dams had a lighter liver but greater white
adipose tissue (retroperitoneal fat, WAT) mass compared
to control dams onD16. Therewere no significant changes
inmaternal biometrywithdiet atD19 (Table 2).HFHSdiet
reduced both fetal and placental weight on D16, whereas
only placental weight remained significantly decreased on
D19 (Tables 1 and 2). There was no effect of diet at either
time point on the ratio of fetal to placental weight per
litter, nor any affect on litter size (Tables 1 and 2).
Metabolites and hormone concentrations
In the fed state, HFHS dams were hyperglycaemic,
hyperinsulinaemic, hyperleptinaemic and hyper-
cholesterolaemic at D16 but not at D19 (Tables 1 and
2). They remained hyperglycaemic in the fasted state at
D16 (Table 1). Plasma TG and IGF1 concentrations were
lower in HFHS compared to control dams at D16 but not
at D19 (Tables 1 and 2). Plasma NEFAs were unaffected at
D16 but were decreased at D19 by HFHS feeding (Tables 1
and 2). There was no effect of a HFHS diet on maternal
plasma corticosterone concentrations on either D16 or
D19 of pregnancy (Tables 1 and 2).
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Figure 2. The effect of HFHS feeding on maternal glucose tolerance in late pregnancy
Glucose tolerance in dams at D16 (A and B) and D19 (C and D) of pregnancy fed control (white symbols and
columns, n = 8–9) or HFHS diets (black symbols or columns, n = 6–7). Changes in blood glucose concentrations
from basal pre-injection values with time after glucose administration (A and C) and AUC (B and D). ∗P < 0.05.
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Tissue biochemical composition
Hepatic protein and glycogen content did not differ with
diet at either stage of pregnancy (Tables 1 and 2). Hepatic
fat content was higher in HFHS compared to control
dams at D19 but not at D16, when expressed both as
total weight and as a proportion of liver weight (Tables 1
and 2). Histological staining confirmed intrahepatic fat
accumulation in D19 HSHF-fed dams (Fig. 1A–D). In
skeletal muscle, protein content was lower, whereas fat
content tended to be higher in HFHS compared to control
dams at D19 only (Table 2). Protein content of WAT was
lower in HFHS compared to control dams at both ages
(Tables 1 and 2).
Glucose tolerance
There was no significant difference in the increment in
blood glucose or in the glucose AUC with diet at D16,
although glucose concentrations appeared to be higher
and remain elevated for longer in HFHS dams (Fig. 2A
and B). At D19, the glucose increment in HFHS dams
was greater at 30, 45 and 60 min compared to control
values (Fig. 2C). Consequently, HSHF feeding led to a
greater AUC (Fig. 2D), indicative of diet-induced glucose
intolerance in late pregnancy.
Insulin sensitivity
Whole body and hepatic insulin sensitivity were examined
by HEC on D19. In both groups, blood glucose
concentrations were clamped at basal, euglycaemic levels
by 70–90 min after beginning insulin infusion (Fig. 3A).
At this time, plasma insulin concentrations were within
the post-prandial range and three- to four-fold higher
than basal values in both groups (Fig. 3B). Whole body
insulin sensitivity, measured as the glucose infusion rate
(GIR), was higher in HFHS compared to control dams
(Fig. 3C). However, when whole body insulin sensitivity
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Figure 3. The effect of HFHS feeding on maternal glucose-insulin dynamics on day 19 of pregnancy
Blood glucose (A) and plasma insulin concentrations (B) in the basal (stippled columns) and hyperinsulinaemic
(striped columns) periods of the hyperinsulinaemic-euglycaemic clamp, rates of glucose infusion (GIR), appearance
(Ra) and disappearance (Rd) measured directly (C) or derived indirectly as differences in rates (D) from tritiated
glucose infusion and the clamp protocol (whole body and hepatic insulin sensitivity and EGP) in control dams
(Con, n = 6, white columns) and HFHS (n = 6, black columns) at D19 of pregnancy. ∗Significant difference in
(B) in concentration from the basal period (P < 0.01, paired t test), within each period of the clamp. ∗Significant
differences in (C) and (D) in rates between diets (P < 0.05, unpaired t test).
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Table 3. The effect of HFHS feeding on glucose utilization by skeletal muscle and adipose tissue of pregnant mice and by the
feto-placental tissues at day 19
p2DG content (nmol mg–1)
Control HFHS
Skeletal muscle 2.03 ± 0.53 0.51 ± 0.49∗
White adipose tissue 1.33 ± 0.83 0.97 ± 0.43
Placenta 5.38 ± 1.16 3.81 ± 0.98
Fetus 1.76 ± 0.31 0.73 ± 0.17∗
Data are expressed as the mean ± SEM for control (n = 6) and HFHS (n = 5–6). ∗Significant difference from control diet (P < 0.05,
unpaired t test).
was calculated as the difference between glucose utilization
in hyperinsulinaemic (Rd) and basal states (Ra), neither
group appeared to be insulin sensitive (paired t test,
P > 0.05 for the difference, both groups) (Fig. 3D). End-
ogenous glucose production (EGP) occurred in basal (Ra)
and hyperglycaemic states (Rd minus GIR) irrespective of
diet (single t test greater than zero, P < 0.05 for all cases)
but was lower with respect to rate in HFHS compared
to control dams in both states (Fig. 3C and D). Hepatic
insulin sensitivity, calculated as a significant decrease in
Control Control HFHSHFHS
InsR
IGF1R
p110α
p110β
p85α
Total Akt
pAkt T308
pAkt S473
pGsk S21/9
Total S6K 
pS6K T389  
Total MAPK
pMAPK T202/4
SREBP
PPARα
PPARγ
LPL
FATP1
FAS
Ponceau
Total Gsk
Total 4EBP
p4EBP S65
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Liver
Day 19
Figure 4. The effect of HFHS feeding on
metabolic signalling pathways in the
maternal liver in late pregnancy
Western blots showing the abundance of
insulin signalling and lipid metabolism proteins
in the liver of dams at D16 (A) and D19 (B) of
pregnancy fed control or HFHS diets.
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EPG between basal and hyperinsulinaemic states, was
detected inbothdietary groups (paired t test,P<0.05) and
was greater in HFHS compared to control dams (Fig. 3D).
In the basal fed state, G6Pase expression was reduced and
PEPCK was not significantly altered In the liver of D19
HFHS-fed dams (Fig. 1E–H).
Whole body and tissue glucose utilization
Whole body glucose utilization was less in HFHS
compared to control dams, in both basal (Ra) and hyper-
insulinaemic (Rd) conditions (Fig. 3C). During hyper-
insulinaemia, tissueglucoseutilization,measuredasp2DG
content, was lower in skeletal muscle of HFHS compared
to control dams but was unaffected by diet in adipose
tissue (Table 3). Fetal but not placental p2DG content was
also lower in HFHS compared to control dams (Table 3).
Maternal tissue insulin/IGF1 signalling and lipid
metabolism
Liver. The hepatic insulin/IGF1 signalling pathway was
stimulated by HFHS feeding (Figs 4 and 5). At D16,
p85α, pAkt T308 and pAktS473 were increased (Fig. 5A).
By D19, pAktS473 remained upregulated and the insulin
receptorwas also increasedbyHSHF feeding (Fig. 5B). The
mTORC1 signalling was disrupted by HFHS diet at both
ages; pS6K was reduced and p4EBP increased at D16 and
the total abundance of S6K was elevated although pS6K
remained lower at D19, in the HFHS-fed dams compared
to controls (Fig. 5).MAPKsignalling and lipidmetabolism
markers were unaffected by a HSHF diet at D16 (Fig. 5A).
AtD19, total andphosphorylatedMAPKwere increased in
HFHSdams (Fig. 5B). Expressionof lipogenic PPARγ, FAS
and LPL was higher, whereas the lipid oxidation protein,
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Figure 5. The effect of HFHS feeding on
the expression of metabolic signalling
pathways in the maternal liver in late
pregnancy
Quantification of insulin signalling and lipid
metabolism proteins in liver of dams at D16
(A) and D19 (B) of pregnancy fed control
(n = 5–6, white columns) or HFHS diets
(n = 5–6, black columns). ∗P < 0.05.
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PPARα was lower in HFHS compared to control dams
(Fig. 5B).
Skeletalmuscle. The insulin/IGF1 signallingpathwaywas
downregulated in the skeletal muscle by HFHS feeding at
both D16 (total Akt, total MAPK, total 4EBP and p4EBP)
and D19 (insulin-like growth factor receptor 1 (IGF1R),
total Akt, pAkt T308, pS6K and p4EBP) (Figs 6 and 7).
Abundance of FATP1 was lower at both ages and FAS
expression higher at D16 but reduced on D19 in HFHS
compared to control dams (Fig. 7). The other markers of
lipid metabolism assessed were unaffected by diet (Figs 6
and 7).
White adipose tissue. HFHS feeding reduced the
insulin/IGF1 signalling pathway in WAT (Figs 8 and 9).
Expression of IGFIR, p110α, p85α, total Akt and total S6K
was lower in HFHS compared to control dams at D16
(Fig. 9A). At D19, IGFIR remained downregulated and
p110β and pAkt S473 additionally reduced in HFHS-fed
compared to control dams (Fig. 9B). WAT expression of
FATP1 was decreased at D16 but normalized by D19,
and PPARα and FAS were decreased at both ages in
HFHS compared to control dams (Fig. 9). 4EBP could
not be detected in WAT. The other marker of mTORC1
signalling, S6K, and MAPK signalling were unaltered by
HSHF feeding (Figs 8 and 9).
Placental Prl/Pl gene expression. Placental expression of
Prl2b1 and Prl7b1 genes was decreased in the placenta at
D16 but normalized byD19 inHFHS compared to control
dams (Fig. 10). There was no effect of HFHS feeding on
the expression of Prl5a1, Prl7a2, Prl3d1, Prl3b1 genes at
either age.
Discussion
The present study shows that excessive consumption
of fat and sugar, typical of a Western-style diet
compromises maternal glucose tolerance and insulin
sensitivity during late mouse pregnancy. These changes
were accompanied by dysregulated lipid and glucose
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p110β
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Figure 6. The effect of HFHS feeding on
metabolic signalling pathways in the maternal
skeletal muscle in late pregnancy
Western blots showing the abundance of insulin
signalling and lipid metabolism proteins in the skeletal
muscle of dams at D16 (A) and D19 (B) of pregnancy
fed control or HFHS diets.
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handling, a disturbed hormone and metabolite milieu,
and altered expression of growth and metabolic signalling
pathways in the liver, skeletal muscle and adipose
tissue of the mother. Moreover, the maternal metabolic
changes induced by HFHS feeding were related to altered
feto-placental glucose metabolism and growth, as well
as Prl/Pl-related gene expression in the placenta. A
HFHS diet during pregnancy therefore, causes maternal
metabolic dysfunction with consequences for maternal
nutrient allocation for fetal growth. These findings have
implications for the health of women and their infants in
theWestern world where HFHS diets are common during
pregnancy.
TheHFHS diet resulted in increasedmaternal adiposity
during pregnancy; there was an expansion of WAT mass
(significant at D16) and accumulation of fat in the
liver and skeletal muscle at D19. Consistent with this,
hepatic, skeletal muscle and WAT expression of lipogenic
proteins were upregulated and/or lipid oxidation markers
downregulated in HFHS dams at D19. Hepatic steatosis
has previously been reported in pregnant rodents fed high
fructose or high-fat diets (Zou et al. 2012; Heerwagen
et al. 2013). However, in the dams of the present study,
the abundance of some lipogenic proteins was decreased,
whichmay be a compensatory response to prevent further
lipid accumulation inmaternal tissueswithHFHS feeding.
In the skeletal muscle andWAT, the accumulation of lipids
came at the expense of tissue protein. This was in line with
diminished signalling via the protein synthesis pathway,
mTORC1, in these tissues, as well as the increased whole
body adiposity but reduced lean mass and dietary protein
intake reported previously for dams on this HFHS diet
(Sferruzzi-Perri et al. 2013). The HFHS diet also affected
conceptus mass, with a reduced weight of the fetus and
placenta on D16 and a reduced placental weight on D19,
as reported previously (Sferruzzi-Perri et al. 2013). Taken
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Figure 7. The effect of HFHS feeding on the
expression of metabolic signalling
pathways in the maternal skeletal muscle
in late pregnancy
Quantification of insulin signalling and lipid
metabolism proteins in skeletal muscle of dams
at D16 (A) and D19 (B) of pregnancy fed control
(n = 5–6, white columns) or HFHS diets
(n = 5–6, black columns). ∗P < 0.05.
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together, these data suggest a global shift in nutrient
partitioning between the dam and gravid uterus with
HFHS feeding.
The HFHS diet also led to abnormal metabolite and
hormone concentrations in the dam during pregnancy,
particularly at D16, in line with previous observations
of obese pregnant women with and without GDM
(Uebel et al. 2014). Plasma triglycerides, weight of the
maternal liver and the liver-derived hormone, IGF1, in
the circulation were all reduced in HFHS dams at D16.
Reduced IGF1 may have contributed to the increased
adiposity and diminished lean mass of HFHS dams
because maternal endocrine IGFI is known to reduce
adiposity and increase amino acid uptake by skeletal
muscle inpregnant guinea-pigs (Sferruzzi-Perri et al.2006;
Sferruzzi-Perri et al. 2007a,b). Hypotriglyceridaemia has
been reported in fructose fed rats that also show increased
adiposity during pregnancy (Jen et al. 1991) and, in both
the present study and previous studies, this may reflect
a redistribution of triglycerides with greater storage in
maternal tissues and less in the circulation. Maternal liver
weight was no longer reduced in HFHS dams at D19 in
the present study, which paralleled an increase in hepatic
activation of the growth-promoting, MAPK signalling
pathway by D19. Moreover, circulating hormones and
metabolites had normalized in HFHS dams by this stage
of pregnancy. Normalization of maternal glycaemia near
termwas also observed previously in pregnant rodents fed
high-fat or sucrose diets (Jen et al. 1991; Liang et al. 2010).
In the present study, plasma NEFAs were lower in HFHS
compared to control dams on D19, which is consistent
with previous observations in near-term pregnant mice
fed high-fat diets (Heerwagen et al. 2013). By contrast, in
obese andGDMwomenNEFAconcentrations are elevated
orunchanged in late pregnancy (Catalano et al.2002;Chen
& Scholl, 2008).
Overall, the hyperinsulinaemia and fasting hyper-
glycaemia seen in theHFHS dams at D16 suggestmaternal
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Figure 8. The effect of HFHS feeding
on metabolic signalling pathways in
the maternal white adipose tissue in
late pregnancy
Western blots showing the abundance of
insulin signalling and lipid metabolism
proteins in the white adipose tissue of
dams at D16 (A) and D19 (B) of pregnancy
fed control or HFHS diets.
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insulin resistance, although overt glucose intolerance
was not observed until D19. Late gestational glucose
intolerance has also been reported in mice fed a HFHS
diet from before pregnancy; however, this was associated
with fetal overgrowth (Rosario et al. 2015), which is
similar to a subset of mothers with obesity. Impaired
pancreatic β cell proliferation may have contributed to
the glucose intolerance of HFHS dams. Proliferation
of the β cells during mouse pregnancy depends on
placental secretion of PRL/PL-related proteins (Brelje
et al. 1993). A HFHS diet reduced placental expression
of Prl/Pl-related genes on D16, which may have had
consequences for β cell proliferation and the ability to
respond to acute hyperglycemia (Huang et al. 2009).
Further experiments measuring insulin concentrations
during the glucose tolerance test are required to establish
the relative importance of insulin secretion vs. insulin
action with respect to the glucose intolerance induced by
HFHS feeding.
At D19, a higher rate of glucose infusion was needed
to maintain euglycaemia in HFHS than control dams.
This was unexpected and suggested that HFHS feeding
increased, rather than decreased, whole body insulin
sensitivity of the dam. However, compared to controls,
the maternal liver of HFHS dams was more sensitive to
insulin at D19 because insulinmore effectively suppressed
EGP, which is consistent with the increased hepatic insulin
receptor abundance. Even at D16, there was evidence of
increasedhepatic insulin signalling inHFHSdamsbecause
phosphoinositol 3-kinase (PI3K)-p85α expression and
Akt activation (pAkt T308 at D16 and pAkt S473 at
both D16 and D19) were enhanced compared to controls.
Increased insulin signalling via the PI3K-Akt pathway
may have contributed to the observed fatty liver in
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* * *Figure 9. The effect of HFHS feeding on
the expression of metabolic signalling
pathways in the maternal white adipose
tissue in late pregnancy
Quantification of insulin signalling and lipid
metabolism proteins in white adipose tissue
of dams at D16 (A) and D19 (B) of pregnancy
fed control (n = 5–6, white columns) or HFHS
diets (n = 5–6, black columns). ∗P < 0.05.
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HFHS-fed dams because deletion of genes in this pathway
protects against high-fat diet-induced hepatic steatosis in
non-pregnant mice (Leavens et al. 2009; Chattopadhyay
et al. 2011). However, whole body glucose utilization
was lower in both basal and hyperinsulinaemic states
and glucose utilization during hyperinsulinaemia by the
skeletal muscle was diminished in HFHS dams. Moreover,
expression of several components of the insulin signalling
pathway was downregulated in the skeletal muscle and
WAT of HFHS dams on D16 and D19 and may have
mediated the decreased expression of lipogenic markers
in these tissues, in contrast to the hepatic data. In line
with this, a diet high in sugar and/or fat reduced insulin
sensitivity index and insulin responsiveness of isolated
fat cells in late pregnant rats (Jen et al. 1991; Holemans
et al. 2004) and decreased whole body insulin sensitivity
and glucose uptake by the hindlimb in pregnant dogs
(Moore et al. 2011; Woolcott et al. 2015). Furthermore,
womenwithGDMdisplayeddecreasedwhole body insulin
sensitivity, skeletal muscle and adipose tissue insulin
signalling and insulin-stimulated glucose uptake during
pregnancy (Garvey et al. 1993; Friedman et al. 1999;
Shao et al. 2000; Catalano et al. 2002; Shao et al. 2002).
Overall, the results of the present study indicate that
HFHS feeding affects tissue insulin resistance in some,
but not all, maternal tissues during mouse pregnancy
(Fig. 11).
At D19, the liver of HFHS-fed dams produced
less glucose endogenously in both basal and hyper-
insulinaemic states than controls. This was coupled to
decreased hepatic expression of G6Pase, the rate-limiting
enzyme involved in gluconeogenesis and glycogenolysis.
G6Pase is inhibited by insulin (van Schaftingen & Gerin,
2002) and its downregulation is consistent with increased
hepatic insulin sensitivity and insulin receptor expression
in HFHS dams. However, HFHS feeding did not cause
an accumulation of glycogen in the maternal liver. This
may have been secondary to the disrupted mTORC1
signalling observed in the liver of HFHS-fed dams because
the mTORC1 pathway regulates glycogen synthase, the
enzyme responsible for producing glycogen (Wang et al.
2011). Reduced maternal glucogenesis is consistent with
a higher dietary sugar intake and would explain the
increased rate of glucose infusion required to maintain
euglycaemia in the HFHS relative to control dams,
especially given the large drain of glucose into the gravid
uterus at D19. By decreasing glucose availability between
feeding periods, the lower rates of gluconeogenesis could
also have contributed to the restricted growth of the
placenta and the lower body weights of the fetuses
observed both in the present and previous studies at D16
(Sferruzzi-Perri et al. 2013), when fetal growth is more
dependent on glucose than amino acid availability (Coan
et al. 2011).
The fetuses of the HFHS dams achieved a normal
weight near term (both in the present and previous
studies; Sferruzzi-Perri et al. 2013). This occurred despite
a smaller placenta and a reduced rate of glucose utilization,
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Figure 10. The effect of HFHS feeding on
placental hormone expression in late
pregnancy
Expression of prolactins/placental
lactogen-related genes by the placenta on D16
(A) and D19 (B) of pregnancy in dams fed a
control (n > 6, white columns) or HFHS diets
(n > 6, black columns). ∗P < 0.05.
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indicated by the lower p2DG accumulation in the HFHS
fetuses atD19. These data suggest that fetuses inHFHS-fed
dams must use substrates other than glucose for growth
and oxidative metabolism during late gestation. Indeed,
previous studies have shown transfer of amino acids
by the System A transporters, per unit surface area, is
increased near term in HSHF-fed dams (Sferruzzi-Perri
et al. 2013; Rosario et al. 2015). Moreover, placental
FATP1 expression was upregulated by HFHS feeding on
D19 (Sferruzzi-Perri et al. 2013) suggesting that there
may also be an increased materno-placental supply of
NEFAs to the HFHS fetuses. Fetal growth is correlated
with placental amino acid but not glucose supply on D19
of mouse pregnancy (Coan et al. 2011) and an increased
maternal supply of fats during pregnancy resulted in fatty
liver in offspring (Elahi et al. 2009; McCurdy et al. 2009;
Ashino et al. 2012; Alfaradhi et al. 2014). Collectively,
these data show that the placental supply and fetal
use of metabolic substrates are altered by a HFHS diet
during pregnancy with potential consequences for fetal
development and the programmingof offspringmetabolic
phenotype (Samuelsson et al. 2008; Sferruzzi-Perri et al.
2013). Further work is required to determine the
relationship between maternal glucose-insulin dynamics
and feto-placental glucose metabolism and growth in pre-
gnancies in which the mother started to eat a HFHS diet
prior to pregnancy.
In summary, HFHS feeding during pregnancy
differentially altered insulin sensitivity ofmaternal tissues,
with increased hepatic insulin sensitivity but decreased
sensitivity of the skeletal muscle andWAT (Fig. 11). These
changes were accompanied by increased adiposity and
reduced glucose production and glucose tolerance of the
dam in late pregnancy. They were also related to impaired
nutrient partitioning between the mother and the gravid
uterus and, hence, feto-placental growth andmetabolism.
The changes inmaternalmetabolism, placental phenotype
(Sferruzzi-Perri et al. 2013) and fetal growth induced by
HFHS feeding during pregnancy may explain, in part,
the early life programming of adult disease by maternal
obesity and obesogenic diets. They may also shed light on
the mechanisms by which altered maternal-fetal resource
allocation during pregnancy increases the risk of poor
health in the mother post-partum.
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Figure 11. HFHS feeding differentially alters metabolic signalling pathways in maternal tissues in late
pregnancy
Schematic showing the effect of a HFHS diet on the expression of insulin signalling and lipid metabolism proteins
in the liver (A) and the peripheral tissues (B, skeletal muscle and white adipose tissue) of the mouse dam
in late pregnancy. Proteins that were upregulated are shown in large black font and in green/grey colour,
whereas proteins that were downregulated are shown in small white font and in red/black colour. IGF1,
insulin like growth factor 1; InsR, insulin receptor; IGF1R, insulin-like growth factor receptor 1; IRS1, insulin
receptor substrate 1; PI3K, phosphoinositide 3-kinase; p85α, the regulatory subunit of PI3K; p110, the catalytic
subunit of PI3K; PIP2, phosphatidylinositol 4,5-biphosphate; PIP3, phosphatidylinositol 3,4,5-phosphate; PDK1,
phosphoinositol-dependent kinase -1; Akt, protein kinase B; Thr308, threonine residue 308 of Akt; Ser473, serine
residue 473 of Akt; GSK3, glycogen synthase kinase 3; Ser9, serine residue of GSK3β; Ser21, serine residue 21
of GSK3α; mTORC1, mechanistic target of rapamycin kinase complex 1; 4EBP, eukaryotic translation initiation
factor 4E binding protein; Ser65, serine residue of 4EBP; S6K, ribosomal S6 kinase; Thr389, threonine residue
of S6K; GLUT4, glucose transporter 4; FFA, free fatty acids; TG, triglycerides; FATP1, fatty acid transport protein
1; LPL, lipoprotein lipase; FABP, fatty acid binding protein; PPARα,γ , peroxisome proliferator-activated receptors;
SREBP, sterol regulatory element binding protein; FAS, fatty acid synthase; Ras, small GTPase protein; Raf, serine
threonine protein kinase; MEK, mitogen extracellular signal regulated kinase; MAPK, mitogen activated protein
kinase; Thr202, threonine residue of MAPK; Tyr204, tyrosine residue of MAPK. [Colour figure can be viewed at
wileyonlinelibrary.com]
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